The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis

Evidence exists for an immunomodulatory effect of endocrine therapy in hormone receptor-positive (HR+ve) breast cancer (BC). Therefore, the aim of this study was to define the prognostic and predictive value of tumor immune markers and the tumor immune profile in HR+ve BC, treated with different end...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Breast Cancer Res Treat
Glavni autori: Engels, C. C., Charehbili, A., van de Velde, C. J. H., Bastiaannet, E., Sajet, A., Putter, H., van Vliet, E. A., van Vlierberghe, R. L. P., Smit, V. T. H. B. M., Bartlett, J. M. S., Seynaeve, C., Liefers, G. J., Kuppen, P. J. K.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2015
Teme:
Preclinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4326646/
https://ncbi.nlm.nih.gov/pubmed/25616355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3269-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items